THE USE OF SIV-INFECTED RHESUS-MONKEYS FOR THE PRECLINICAL EVALUATION OF AIDS DRUGS AND VACCINES

被引:32
作者
WYAND, MS
机构
[1] TS1 Mason Laboratories, Worcester, MA 01068
关键词
D O I
10.1089/aid.1992.8.349
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macaque monkeys infected with the simian immunodeficiency virus (SIV) can be used for preclinical testing of drugs and vaccines against acquired immunodeficiency syndrome (AIDS) as well as for the study of AIDS pathogenesis. A number of pathogenic SIV strains that have been well characterized molecularly and biologically are available for animal infection studies. Data generated from in vitro drug sensitivity assays have established, for many classes of compounds, a similar degree of antiviral efficacy against both HIV-1 and the SIVs, although some examples of selective inhibitors of HIV-1 now are known. A number of virus and host parameters have been defined that provide suitable biological endpoints for in vivo efficacy studies during acute and chronic infection of macaque monkeys. Vaccine studies in SIV-infected monkeys have provided hope that immune protection against lentiviruses is possible; SIV systems are playing a major role in systematically comparing various vaccine strategies to determine correlates of immunity and the protection required for mucosal versus parenteral routes of infection. Societal pressures and the expanding AIDS epidemic will continue to encourage early testing of experimental drugs and vaccines in human clinical trials, however, as more data validating the SIV system are generated, the utility of the SIV model in preclinical development likely will become apparent. Impetus to evaluate therapies in this model system will increase if the current method of testing in humans does not identify more effective AIDS therapies in the near future.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 84 条
[1]   TRANSMISSION OF HTLV-III INFECTION FROM HUMAN-PLASMA TO CHIMPANZEES - AN ANIMAL-MODEL FOR AIDS [J].
ALTER, HJ ;
EICHBERG, JW ;
MASUR, H ;
SAXINGER, WC ;
GALLO, R ;
MACHER, AM ;
LANE, HC ;
FAUCI, AS .
SCIENCE, 1984, 226 (4674) :549-552
[2]   AN INHIBITOR OF THE PROTEASE BLOCKS MATURATION OF HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES AND SPREAD OF INFECTION [J].
ASHORN, P ;
MCQUADE, TJ ;
THAISRIVONGS, S ;
TOMASSELLI, AG ;
TARPLEY, WG ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7472-7476
[3]   THE INVITRO AND INVIVO ANTI-RETROVIRUS ACTIVITY, AND INTRACELLULAR METABOLISM OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE AND 2',3'-DIDEOXYCYTIDINE ARE HIGHLY DEPENDENT ON THE CELL SPECIES [J].
BALZARINI, J ;
PAUWELS, R ;
BABA, M ;
HERDEWIJN, P ;
DECLERCQ, E ;
BRODER, S ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :897-903
[4]   ALPHA-(1-3)-D-MANNOSE-SPECIFIC AND ALPHA-(1-6)-D-MANNOSE-SPECIFIC PLANT-LECTINS ARE MARKEDLY INHIBITORY TO HUMAN-IMMUNODEFICIENCY-VIRUS AND CYTOMEGALOVIRUS INFECTIONS INVITRO [J].
BALZARINI, J ;
SCHOLS, D ;
NEYTS, J ;
VANDAMME, E ;
PEUMANS, W ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :410-416
[5]   ISOLATION OF A LENTIVIRUS FROM A MACAQUE WITH LYMPHOMA - COMPARISON WITH HTLV-III/LAV AND OTHER LENTIVIRUSES [J].
BENVENISTE, RE ;
ARTHUR, LO ;
TSAI, CC ;
SOWDER, R ;
COPELAND, TD ;
HENDERSON, LE ;
OROSZLAN, S .
JOURNAL OF VIROLOGY, 1986, 60 (02) :483-490
[6]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 CHALLENGE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT ENVELOPE GLYCOPROTEIN GP120 [J].
BERMAN, PW ;
GROOPMAN, JE ;
GREGORY, T ;
CLAPHAM, PR ;
WEISS, RA ;
FERRIANI, R ;
RIDDLE, L ;
SHIMASAKI, C ;
LUCAS, C ;
LASKY, LA ;
EICHBERG, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5200-5204
[7]   PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].
BERMAN, PW ;
GREGORY, TJ ;
RIDDLE, L ;
NAKAMURA, GR ;
CHAMPE, MA ;
PORTER, JP ;
WURM, FM ;
HERSHBERG, RD ;
COBB, EK ;
EICHBERG, JW .
NATURE, 1990, 345 (6276) :622-625
[8]   VACCINE PROTECTION OF RHESUS MACAQUES AGAINST SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
CARLSON, JR ;
MCGRAW, TP ;
KEDDIE, E ;
YEE, JL ;
ROSENTHAL, A ;
LANGLOIS, AJ ;
DICKOVER, R ;
DONOVAN, R ;
LUCIW, PA ;
JENNINGS, MB ;
GARDNER, MB .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) :1239-1246
[9]   EFFECT OF ZIDOVUDINE ON SERUM HUMAN IMMUNODEFICIENCY VIRUS CORE ANTIGEN LEVELS - RESULTS FROM A PLACEBO-CONTROLLED TRIAL [J].
CHAISSON, RE ;
LEUTHER, MD ;
ALLAIN, JP ;
NUSINOFFLEHRMAN, S ;
BOONE, GS ;
FEIGAL, D ;
VOLBERDING, P .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (10) :2151-2153
[10]   SEQUENCE OF SIMIAN IMMUNODEFICIENCY VIRUS FROM MACAQUE AND ITS RELATIONSHIP TO OTHER HUMAN AND SIMIAN RETROVIRUSES [J].
CHAKRABARTI, L ;
GUYADER, M ;
ALIZON, M ;
DANIEL, MD ;
DESROSIERS, RC ;
TIOLLAIS, P ;
SONIGO, P .
NATURE, 1987, 328 (6130) :543-547